Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REACH: Dapivirine Ring vs Oral PrEP in Young Women
NCT03074786Phase 2Withdrawn
- Sponsor
- International Partnership for Microbicides
- Start
- Nov 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dapivirine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by International Partnership for Microbicides. Planned start Nov 2017; status: withdrawn.
02
Drugs
dapivirine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT03074786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03074786.